Mabpharm Limited(HK:2181)
HK$0.49+0.05 (+11.36%)
HK:2181
Mabpharm Limited financials statements
HK$0.49
At close:+0.05 (+11.36%)
Want to see HK:2181 full AI Analyst Report?
Mabpharm Limited (2181) Income Statement
0 Followers
Mabpharm Limited Income Statement
Last quarter (Q2 2026), Mabpharm Limited's total revenue was ¥398.38M, an increase of 267.23% from the same quarter last year. In Q2, Mabpharm Limited's net income was ¥31.39M. See Mabpharm Limited’s key income statements, including revenue, expenses, profit, and income.
| Income Statement | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| ¥ 629.37M | ¥ 258.23M | ¥ 87.16M | ¥ 55.92M | ¥ 82.88M | |
| ¥ 521.55M | ¥ 219.39M | ¥ 75.24M | ¥ 40.54M | ¥ 66.11M | |
| ¥ 516.87M | ¥ 339.07M | ¥ 277.22M | ¥ 266.79M | ¥ 363.63M | |
| Depreciation and Amortization | ¥ 59.78M | ¥ 61.33M | ¥ 60.70M | ¥ 51.55M | ¥ 43.88M |
| ¥ 64.46M | ¥ -58.34M | ¥ -139.08M | ¥ -152.08M | ¥ -245.46M | |
| ¥ 4.68M | ¥ -119.67M | ¥ -201.98M | ¥ -226.25M | ¥ -297.52M | |
| ¥ -626.36K | ¥ -8.28M | ¥ -7.37M | ¥ 15.43M | ¥ 5.78M | |
| ¥ 4.05M | ¥ -127.95M | ¥ -209.36M | ¥ -210.82M | ¥ -291.74M | |
| ¥ 55.65M | ¥ -127.95M | ¥ -209.36M | ¥ -210.62M | ¥ -291.74M | |
| Per Share Metrics | |||||
| Basic EPS | ¥ 0.01 | ¥ -0.03 | ¥ -0.05 | ¥ -0.05 | ¥ -0.07 |
| Diluted EPS | ¥ 0.01 | ¥ -0.03 | ¥ -0.05 | ¥ -0.05 | ¥ -0.07 |
| Weighted Average Shares Outstanding | 4.12B | 4.12B | 4.12B | 4.12B | 4.12B |
| Weighted Average Shares Outstanding (Diluted) | 4.12B | 4.12B | 4.12B | 4.12B | 4.12B |
Currency in CNY
